Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, MAT

Leafreport Uncovers Massive Price Gaps Up to 3200% in CBD Products

TEL AVIV, Israel, Jan. 9, 2020 /PRNewswire/ -- For an industry that's projected to reach $20 billion by 2024 in the U.S. alone, the CBD (cannabidiol) market continues to baffle the general public.

The CBD Market 2020 - Consumer Research Insights by Leafreport.com (PRNewsfoto/Leafreport)

That is, until now.

Leafreport, the web's premier source for CBD information, has successfully compiled an ambitious market report that compares over 3,500 products from more than 53 brands ? including tinctures, gummies, capsules, pet products, topicals, isolates, e-liquids & vaporizers, and bundles.

"What we encountered was a wild, wild west scenario in terms of manufacturing and marketing. There's no uniformity in terms of quality, concentrations, prices or even labeling," Noa Gans, the Head of Product for Leafreport, said in a statement. "Newcomers to CBD have simply been unable to shop wisely."

Amid this daunting landscape, the results offer a first-of-its-kind roadmap for consumers of all stripes.

Pointing to the most surprising findings, Gans cited huge discrepancies between prices for similar products -- including 250% among vaporizers, 1,000% between tinctures, and a staggering 3,200% overall.

"We've successfully created benchmarks that answer nearly any question a curious CBD user could encounter," Gans noted. "Whether its potency or price points, this report gets to the heart of what everybody needs to know."

The document is all part of Leafreport's efforts to provide new tools and information aimed at demystifying the world surrounding cannabis-derived compounds.

And with recent polling showing that 14% of Americans are using CBD for everything from pain relief to sleep aids, their work can not come at a more important time.

"With the industry growing at such a rapid pace, an educated consumer base is absolutely vital," Gans explained. "Transparency and the hunt for the truth has to come above everything else."

About Leafreport

The company's mission is to introduce transparency into the CBD industry through its public database of comprehensive product reviews, comparisons, information, and education about CBD. Medical reviews are a core service and competitive advantage for Leafreport over other online sources. Leafreports' Medical Reviews are provided by vetted members of the medical and scientific community to ensure accurate, current, and patient-focused content.

For more information and clarification, contact us at Leafreport.com, or contact Noa Gans at noa@leafreport.com


SOURCE Leafreport

These press releases may also interest you

at 08:10
FirstWave Bio, Inc., a clinical-stage biotechnology company developing novel gut-targeted small molecules for inflammatory bowel disease and other serious conditions, today announced plans to initiate a Phase 2a/2b study in patients with COVID-19,...

at 08:10
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced the closing of its previously announced sale of stock to Biogen Inc. and that the global licensing collaboration agreement with Biogen for the development and commercialization...

at 08:05
Merck , known as MSD outside the United States and Canada, announced today a commitment to strengthen health systems affected by the COVID-19 pandemic. Through Merck for Mothers, the company's global initiative to help end preventable maternal...

at 08:05
A new startup, i2O Therapeutics, has launched to commercialize innovations developed at Harvard University that may one day enable patients and clinicians to give up syringes in favor of pills. Using ionic liquid technologies developed in the lab...

at 08:05
X4 Pharmaceuticals, Inc. , a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present and conduct one-on-one meetings during the...

at 08:05
i2O Therapeutics, an innovative biotech company developing a platform for oral delivery of traditionally injectable biological drugs, announced today it has raised a $4 million seed funding round led by Sanofi Ventures and JDRF T1D Fund. Founded by...

News published on 9 january 2020 at 11:15 and distributed by: